Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs Xencor
Over the past year NAMS returned −46.2% and XNCR returned +119.8%; their daily moves had a correlation of 0.35.
NAMS −46.2% XNCR +119.8%Growth of $1, one year, split-adjusted
| Metric | NAMS | XNCR |
|---|---|---|
| Price | $19.90 | $30.64 |
| Market cap | $2.38B | $2.28B |
| Today | +1.74% | +3.30% |
| 1 month | −12.7% | +19.5% |
| 6 months | −33.3% | +138.4% |
| Year to date | −43.3% | +100.1% |
| 1 year | −47.6% | +108.3% |
| Revenue growth (YoY) | −80.7% | +17.5% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1732.9% | −42.4% |
| P/E (TTM) | — | — |
| Price / sales | 334.1× | 21.7× |
| Net cash | $633.9M | $351.6M |
| Dividend yield | — | — |
| Volatility (60d) | 51.2% | 62.0% |
| Short % of float | 16.4% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).